Abbott, J&J to bulk up in Europe, vaccines

AMSTERDAM/BRUSSELS (Reuters) – U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday, aimed at securing vaccines and other products key to future growth.

Leave a Reply